Sensei Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 05/20/2026 | 722.02 K | $22.76 M | 100.00% | 55.75% |
| WOODLINE PARTNERS LP | 05/15/2026 | 361.01 K | $11.38 M | 100.00% | 27.88% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2026 | 306.22 K | $9.65 M | 100.00% | 23.65% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 146.57 K | $4.62 M | 100.00% | 11.32% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 133.51 K | $4.21 M | 100.00% | 10.31% |
| STEMPOINT CAPITAL LP | 05/18/2026 | 132.87 K | $4.19 M | 100.00% | 10.26% |
| CALIGAN PARTNERS LP | 05/15/2026 | 126.00 K | $3.97 M | 100.00% | 9.73% |
| 05/15/2026 | 125.00 K | $3.94 M | 100.00% | 9.65% | |
| MARSHALL WACE, LLP | 05/15/2026 | 65.73 K | $2.07 M | 100.00% | 5.08% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 61.57 K | $1.94 M | 100.00% | 4.75% |
| HRT FINANCIAL LP | 05/14/2026 | 58.00 K | $1.83 M | 100.00% | 4.48% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 34.55 K | $1.09 M | 100.00% | 2.67% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 33.03 K | $1.04 M | 10,692.48% | 2.55% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 32.04 K | $1.01 M | 178.23% | 2.47% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 30.00 K | $945.60 K | 100.00% | 2.32% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 26.12 K | $823.43 K | 100.00% | 2.02% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 05/15/2026 | 20.33 K | $640.90 K | 100.00% | 1.57% |
| FRED ALGER MANAGEMENT, LLC | 05/15/2026 | 18.34 K | $577.98 K | 100.00% | 1.42% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 16.21 K | $510.78 K | 100.00% | 1.25% |
| CATALIO CAPITAL MANAGEMENT, LP | 05/15/2026 | 14.72 K | $463.91 K | 0.00% | 1.14% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 9.50 K | $299.52 K | 100.00% | 0.73% |
| JANE STREET GROUP, LLC | 05/12/2026 | 8.87 K | $279.65 K | 100.00% | 0.69% |
| MORGAN STANLEY | 05/15/2026 | 8.80 K | $277.22 K | 87,850.00% | 0.68% |
| 05/15/2026 | 7.75 K | $244.28 K | 100.00% | 0.60% | |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 6.35 K | $200.18 K | -70.25% | 0.49% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 6.31 K | $198.80 K | 100.00% | 0.49% |
| UBS GROUP AG | 05/05/2026 | 4.53 K | $142.75 K | 100.00% | 0.35% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 1.50 K | $47.15 K | 100.00% | 0.12% |
| JPMORGAN CHASE & CO | 05/13/2026 | 32 | $804 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 9 | $284 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 4 | $126 | 0.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Sensei Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 35 institutional investors and hedge funds held shares of Sensei Biotherapeutics Inc. The most heavily invested institutionals were:
Vivo Capital, LLC: 722,020
Woodline Partners LP: 361,010
Cormorant Asset Management, LP: 306,222
MILLENNIUM MANAGEMENT LLC: 146,565
FRANKLIN RESOURCES INC: 133,506
StemPoint Capital LP: 132,873
194.39% of Sensei Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 2.43 M shares in the last 24 months. This purchase volume represents approximately $71.68 M in transactions.